Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Total Stockholders Equity : $-13.28 Mil (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Total Stockholders Equity?

Parnell Pharmaceuticals Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2018 was $-13.28 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Parnell Pharmaceuticals Holdings's Book Value per Share for the quarter that ended in Dec. 2018 was $-0.74. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Parnell Pharmaceuticals Holdings's Debt-to-Equity for the quarter that ended in Dec. 2018 was -2.43.

Parnell Pharmaceuticals Holdings Total Stockholders Equity Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Total Stockholders Equity Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Total Stockholders Equity

Get a 7-Day Free Trial

34.43

14.68

5.93

-8.65

-13.28

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Total Stockholders Equity	Get a 7-Day Free Trial			34.43	14.68	5.93	-8.65	-13.28

Parnell Pharmaceuticals Holdings (OTCPK:PARNF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Parnell Pharmaceuticals Holdings's Book Value per Share for the quarter that ended in Dec. 2018 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-13.282	-	0)	/	18.027
	=	-0.74

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Parnell Pharmaceuticals Holdings's Debt-to-Equity for the quarter that ended in Dec. 2018 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.007	+	32.282)	/	-13.282
	=	-2.43

Parnell Pharmaceuticals Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Parnell Pharmaceuticals Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.